Fineman Steven W MD is categorized under Internal Medicine Doctors in Sarasota, FL and active since 2010.
Fineman Steven W MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Steven Fineman at the company’s single location by writing to 1921 Waldemere St # 413, Sarasota, Florida FL 34239 or by phoning (941) 917-6585. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Fineman Steven W MD |
| Contact Person: | Steven Fineman |
| Address: | 1921 Waldemere St # 413, Sarasota, Florida 34239 |
| Phone Number: | (941) 917-6585 |
| Website Address: | sarasotakidney.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Fineman Steven W MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Steven Fineman for inquiries that concern Fineman Steven W MD by calling the company number (941) 917-6585, as your correspondence is most welcome. Additionally, the physical location of the single location of Fineman Steven W MD can be found at the coordinates 27.31923,-82.53131 as well as the street address 1921 Waldemere St # 413 in Sarasota, Florida 34239.
For its online presence, you may visit Fineman Steven W MD’s website at sarasotakidney.com and engage with its social media outlets through on Twitter and on Facebook.